美国泌尿外科协会症状指数在评估储尿期症状时缺乏内部一致性
该研究评估了AUA-SI在男性和女性中评估下尿路症状的效度。在社区队列(n=1551)和就医队列(n=1083)中,AUA-SI对排尿期症状的内部一致性良好(McDonald's omega>0.7),但对储尿期症状较差(男性0.61,女性0.56)。AUA-SI与其他泌尿症状量表的相关性较弱,尤其在女性和储尿期症状相关生活质量方面。结论认为AUA-SI在评估储尿期症状时表现不佳,临床应谨慎用于未经验证的用途。
要点
- AUA-SI对排尿期症状内部一致性良好,但对储尿期症状较差。
- AUA-SI与其他泌尿症状量表的相关性弱,尤其在女性。
- 临床应谨慎将AUA-SI用于女性储尿期功能障碍等未验证用途。
核心结论
- AUA-SI对男性BPH相关排尿期症状评估有效,但对储尿期症状及女性评估效果差。
研究设计与样本
- 研究评估AUA-SI在社区代表性队列(n=1551)和全国就医队列(n=1083)中的内部一致性和重测信度。
主要发现
- 男性排尿期症状更重,女性储尿期症状更重。
- AUA-SI排尿期症状的McDonald's omega>0.7,储尿期症状男性0.61、女性0.56。
- AUA-SI与其他泌尿症状量表(LUTS tool、ICIQ-LUTS)的Spearman相关系数较差,尤其女性和储尿期症状相关生活质量。
临床怎么用
- AUA-SI可用于男性BPH排尿期症状评估,但应避免用于女性储尿期功能障碍等未验证用途。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the validity of the American Urological Association Symptom Index (AUA-SI) to assess varied lower urinary tract symptoms in men and women. METHODS: Internal consistency and test-retest reliability of the AUA-SI were assessed in a community-dwelling cohort representative of the United States population (n = 1551) and a national care-seeking cohort (n = 1083). We also examined correlations of the AUA-SI subscale and total scores with validated urinary symptom severity measures, the lower urinary tract symptoms tool (LUTS tool), and gender-specific versions of the International Consultation on Incontinence Questionnaire-lower urinary tract symptoms (ICIQ-LUTS). RESULTS: Men demonstrated more severe voiding phase symptoms, while women exhibited more storage phase symptoms. Internal consistency of the AUA-SI, measured by McDonald's omega, was >0.7 for the assessment of voiding-phase lower urinary tract symptoms, but performed poorly for storage symptoms at 0.61 and 0.56 for men and women, respectively. Spearman's correlation coefficients between the AUA-SI and other survey instruments assessing urinary symptoms were poor, particularly for women and storage lower urinary tract symptoms-related quality of life. CONCLUSION: The AUA-SI is a validated symptom score with high internal consistency and reliability for assessing men with benign prostatic hyperplasia, but is broadly used to assess women and men with lower urinary tract symptoms. While validated for use in men with benign prostatic hyperplasia, the AUA-SI performs poorly in evaluating storage lower urinary tract symptoms and related quality-of-life, particularly in women. Clinicians should use caution in non-validated uses of the AUA-SI, particularly for female storage voiding dysfunction.
引用
- Sadun TY, Cisneros C, Dixon E, et al. American Urological Association-symptom Index Lacks Internal Consistency for Measuring Storage Voiding Symptoms. Urology. 2026. PMID: 41839240. doi:10.1016/j.urology.2026.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。